answersLogoWhite

0

Zomig, which contains the active ingredient zolmitriptan, was first approved by the U.S. Food and Drug Administration (FDA) in 1997 for the treatment of migraine. It was developed by AstraZeneca and has since been made available in various formulations, including tablets and nasal spray. The medication is part of a class of drugs known as triptans, specifically designed to treat acute migraine attacks.

User Avatar

AnswerBot

2w ago

What else can I help you with?